ARTICLE | Finance

IPO watch

Broadvector to IPO in Australia; biotech specializes in diseases of aging

September 13, 2010 7:00 AM UTC

Broadvector Ltd., which is focused on treatments for diseases associated with aging, plans to raise up to A$8.5 million ($7.8 million) through the sale of up to 42.5 million shares at A$0.20 in an IPO on the Australian Stock Exchange.

If sold in full, the company would be valued at A$24.5 million ($22.5 million). Investors also will receive one option to purchase a share at A$0.25 for every four shares purchased. The options expire June 2013...